Innoviz Technologies Ltd. current report, Q3 FY2022

Innoviz Technologies Ltd. — Form 6-K Summary

Business Context and Reporting Period

Innoviz Technologies Ltd., an Israel-based developer of LiDAR sensors, filed this Form 6-K for September 2022. The filing reports a September 8, 2022 announcement regarding a new automotive customer relationship.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other quantitative financial metrics.

Material Change Versus Prior Period

Innoviz announced that a leading Asia-based automotive original equipment manufacturer selected it as a direct LiDAR supplier for series-production passenger vehicles. Innoviz expects to supply InnovizTwo LiDAR sensors for vehicles intended to support an upgrade to full Level 3 automation.

The partnership is expected to generate revenue beginning in fiscal year 2024. The filing characterizes this as Innoviz’s fourth design win.

Guidance, Outlook, and Risks

  • The expected fiscal 2024 revenue contribution is forward-looking and does not include a dollar amount or production-volume estimate.
  • Definitive agreements between Innoviz and the OEM remained to be finalized, creating execution and commercial risk.
  • Additional risks include the anticipated technological capabilities of the products, market conditions, future operating results, and other risks described in Innoviz’s 2021 Form 20-F and subsequent SEC filings.
  • Actual events and results may differ materially from the company’s expectations, and Innoviz does not undertake to update its forward-looking statements.

Investor Verification Items

  • Verify execution and terms of the definitive OEM agreements.
  • Confirm vehicle production timing, volumes, pricing, and the expected magnitude of fiscal 2024 revenue.
  • Assess InnovizTwo validation, regulatory and customer-acceptance requirements, and production readiness.
  • Review the company’s latest financial statements for liquidity, funding needs, operating losses, and commercialization risks.